Matinas BioPharma Holdings, Inc. (MTNB)
Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential therapeutic products. The company's innovative Lipid Nanocrystal (LNC) platform technology underpins its product development efforts. This sophisticated LNC delivery system leverages lipid nano-crystals to transport a diverse array of therapeutic agents, including small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its primary experimental drug, LYPDISO, is a proprietary, prescription-grade omega-3 free fatty acid compound engineered to address cardiovascular and metabolic disorders. Matinas BioPharma is also advancing MAT2203, an orally administered version of amphotericin B. This candidate is currently in Phase II clinical trials, where it is being evaluated for its ability to prevent invasive fungal infections in patients undergoing immunosuppressive treatment. Furthermore, MAT2501, an oral formulation of the broad-spectrum aminoglycoside antibiotic amikacin, has successfully completed Phase I clinical trials. Its aim is to combat a spectrum of multidrug-resistant bacterial infections, such as non-tuberculous mycobacterium, multidrug-resistant gram-negative, and intracellular bacterial pathogens. The company actively engages in collaborations, including a research partnership with the National Institute of Allergy and Infectious Diseases (NIAID) to further the development of Gilead's antiviral drug, remdesivir. Additionally, it has a feasibility collaboration with Genentech, Inc. focused on creating new oral drug formulations. Established in 2013, Matinas BioPharma maintains its corporate headquarters in Bedminster, New Jersey.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Matinas BioPharma Holdings, Inc.
Nasdaq bars a compliance period at 1:250
- 1:15Reverse splitSep 28, 202615 shares → 1
- 1:50Reverse splitSep 3, 202450 shares → 1
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Revenue | $0 | $0 | $1.1M | $3.19M | $33K | $158K | $90K | $120K | $150K | $0 | $194K | $0 | $0 | $0 |
| YoY Growth | - | - | -65.6% | 9560.6% | -79.2% | 76.3% | -25.0% | -20.0% | - | - | - | - | - | - |
| Cost of Revenue | $456K | $972K | $941K | $16.68M | $14.58M | $14.36M | $11.23M | $6.79M | $9.01M | $53K | $5.29M | $5.18M | $0 | $0 |
| Gross Profit | -$456K | -$972K | $155K | -$13.49M | -$14.55M | -$14.2M | -$11.14M | -$6.67M | -$8.86M | -$53K | -$5.1M | -$5.18M | $0 | $0 |
| Gross Margin | - | - | 14.1% | -423.1% | -44090.9% | -8968.8% | -12409.0% | -5568.0% | -5919.6% | - | -2621.0% | - | - | - |
| Research and Development | $85K | $11.43M | $14.49M | $16.68M | $14.58M | $14.36M | $11.23M | $6.79M | $9.01M | $3.95M | $5.29M | $5.18M | $1.76M | $79K |
| Selling, General, and Administrative | $6.88M | $7.76M | $9.43M | $11.1M | $10.19M | $10.01M | $7.78M | $7.98M | $7.64M | $4.31M | $4.81M | $5.29M | $1.95M | $37K |
| Other | -$456K | $0 | $0 | -$16.68M | -$14.58M | -$14.36M | -$11.23M | $57K | $22K | -$17K | $20K | -$25K | -$688 | $0 |
| Total Operating Expenses | $6.5M | $19.19M | $23.92M | $11.1M | $10.19M | $10.01M | $7.78M | $14.77M | $16.65M | $8.26M | $10.11M | $10.46M | $3.71M | $116K |
| Operating Income (EBIT) | -$6.96M | -$20.16M | -$23.77M | -$24.59M | -$24.73M | -$24.21M | -$18.92M | -$14.65M | -$16.5M | -$8.26M | -$9.91M | -$10.46M | -$3.71M | -$116K |
| Operating Margin | - | - | -2168.4% | -771.3% | -74954.5% | -15288.4% | -21067.4% | -12230.9% | -11024.6% | - | -5096.0% | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$3.38M | -$4.17M | $824K | $3.59M | $1.45M | $1.76M | $1.55M | $57K | $659K | $658K | $776K | $244K | -$688 | $0 |
| Income Before Tax (EBT) | -$10.35M | -$24.33M | -$22.94M | -$21M | -$23.28M | -$22.45M | -$17.37M | -$14.59M | -$15.84M | -$7.6M | -$9.14M | -$10.22M | -$3.71M | -$116K |
| Income Tax Expense | $0 | -$80K | $0 | $0 | $0 | $0 | $0 | -$507K | -$357K | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$10.35M | -$24.25M | -$22.94M | -$21M | -$23.28M | -$22.45M | -$17.37M | -$14.08M | -$15.49M | -$7.6M | -$9.14M | -$10.22M | -$3.71M | -$116K |
| Net Income Margin | - | - | -2093.2% | -658.6% | -70554.5% | -14177.0% | -19343.4% | -11760.4% | -10345.9% | - | -4697.0% | - | - | - |
| Supplementary Data | ||||||||||||||
| EPS | -30.00 | -74.70 | -79.20 | -45.00 | -75.60 | -78.45 | -80.55 | -107.70 | -128.40 | -98.85 | -133.05 | -238.95 | -87.00 | -8.70 |
| Diluted EPS | -30.00 | -74.70 | -79.20 | -45.00 | -75.60 | -78.45 | -80.55 | -107.70 | -128.40 | -98.85 | -133.05 | -238.95 | -87.00 | -8.70 |
| Weighted Average OS | 364,942 | 324,389 | 289,686 | 289,082 | 280,238 | 262,526 | 193,594 | 130,804 | 120,633 | 76,873 | 68,641 | 42,769 | 42,667 | 13,333 |
| EBITDA | -$9.89M | -$19.19M | -$22M | -$20.1M | -$22.5M | -$23.43M | -$18.14M | -$14.43M | -$16.4M | -$8.2M | -$9.87M | -$10.42M | -$3.71M | $116K |
| EBITDA Margin | - | - | -2007.4% | -630.5% | -68187.9% | -14799.2% | -20198.0% | -12048.6% | -10957.4% | - | -5073.7% | - | - | - |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $4M | $7.28M | $4.79M | $6.88M | $21.03M | $12.43M | $22.17M | $12.45M | $7.31M | $4.11M | $3.23M | $2.59M | $10.84M | $424K |
| Short-Term Investments | $0 | $0 | $8.97M | $21.93M | $28.59M | $46.25M | $5.61M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $4M | $7.28M | $13.76M | $28.81M | $49.62M | $58.68M | $27.77M | $12.45M | $7.31M | $4.11M | $3.23M | $2.59M | $10.84M | $424K |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $76K | $741K | $50K | $5.72M | $50K | $136K | $250K | $100K | $155K | $156K | $100K | $100K | $0 | $0 |
| Total Current Assets | $4.08M | $8.03M | $15.54M | $34.53M | $50.99M | $61.55M | $29.92M | $13.09M | $7.96M | $4.57M | $3.56M | $2.81M | $10.92M | $424K |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $673K | $2.16M | $5.01M | $5.73M | $5.78M | $4.86M | $5.63M | $2.04M | $1.57M | $356K | $378K | $340K | $93K | $0 |
| Goodwill | $0 | $0 | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $0 | $0 | $0 |
| Intangible Assets | $2.26M | $2.26M | $3.02M | $3.02M | $3.02M | $3.02M | $3.02M | $3.02M | $3.02M | $3.02M | $3.02M | $0 | $0 | $0 |
| Long-Term Investments | $200K | $200K | $0 | $200K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $34.05M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $200K | $0 | $200K | $200K | $336K | $461K | $536K | $541K | $115K | $216K | $316K | $0 |
| Total Long-Term Assets | $3.13M | $4.62M | $9.56M | $44.33M | $10.33M | $9.41M | $10.32M | $6.86M | $6.46M | $5.25M | $4.85M | $556K | $409K | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $7.21M | $12.64M | $25.1M | $78.87M | $61.33M | $70.97M | $40.24M | $19.94M | $14.42M | $9.82M | $8.41M | $3.36M | $11.33M | $424K |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $315K | $95K | $514K | $618K | $937K | $350K | $679K | $296K | $583K | $476K | $498K | $271K | $397K | $60K |
| Short-Term Debt | $696K | $0 | $0 | $569K | $0 | $0 | $0 | $200K | $170K | $118K | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $809K | $33K | $643K | $100K | -$83K | $30K | $0 | $608K | $758K | $0 | $0 |
| Other Current Liabilities | $452K | $4K | $271K | $585K | $899K | $329 | $862K | $1.63M | $0 | $11K | $9K | $0 | $0 | $24K |
| Total Current Liabilities | $1.46M | $2.67M | $2.62M | $4.29M | $4.35M | $3.57M | $3.1M | $2.84M | $2.22M | $1.44M | $1.13M | $1.12M | $859K | $84K |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $3.75B | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | -$341K | -$108K | -$247K | -$1.21M | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $257K | $257K | $341K | $34.39M | $341K | $341K | $341K | $341K | $848K | $1.21M | $1.21M | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | -$3.75B | $513K | $601K | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $915K | $2.38M | $3.24M | $37.94M | $4.48M | $3.67M | $4.09M | $962K | $1.52M | $1.22M | $1.21M | $15K | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.38M | $5.05M | $5.86M | $42.23M | $8.83M | $7.24M | $7.19M | $3.8M | $3.74M | $2.67M | $2.33M | $1.13M | $859K | $84K |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $3.8M | $3.99M | $9.78M | $5.72M | $6.09M | $0 | $0 | $0 | $457K |
| Common Stock | $1K | $1K | $22K | $22K | $22K | $20K | $16K | $11K | $9K | $6K | $6K | $3K | $3K | $1K |
| Retained Earnings | -$210.79M | -$199.82M | -$175.57M | -$152.63M | -$131.63M | -$107.51M | -$84.38M | -$65.94M | -$51.27M | -$35.18M | -$23.19M | -$14.05M | -$3.83M | -$118K |
| Comprehensive Income & Other | $0 | $0 | -$221K | -$824K | -$145K | $228K | -$1K | -$439K | -$0 | $0 | -$0 | -$0 | $0 | $0 |
| Other Stockholders' Equity | $215.62M | $207.41M | $194.8M | $189.25M | $184.11M | $171.22M | $117.41M | $82.08M | $61.95M | $42.32M | $29.25M | $16.28M | $14.3M | $457K |
| Total Equity | $4.83M | $7.59M | $19.25M | $36.64M | $52.49M | $63.73M | $33.05M | $16.14M | $10.68M | $7.15M | $6.07M | $2.23M | $10.47M | $340K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $7.21M | $12.64M | $25.1M | $78.87M | $61.33M | $70.97M | $40.24M | $19.94M | $14.42M | $9.82M | $8.41M | $3.36M | $11.33M | $424K |
| Supplementary Data | ||||||||||||||
| Total Debt | $1.35M | $2.89M | $3.56M | $4.12M | $4.7M | $3.75M | $4.23M | $391K | $265K | $144K | $11K | $60K | $0 | $0 |
| Net Debt | -$2.65M | -$4.39M | -$1.23M | -$2.76M | -$16.33M | -$8.68M | -$17.94M | -$12.06M | -$7.04M | -$3.96M | -$3.22M | -$2.53M | -$10.84M | -$424K |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Operating Activities | ||||||||||||||
| Net Income | -$10.35M | -$24.25M | -$22.94M | -$21M | -$23.28M | -$22.45M | -$17.37M | -$14.08M | -$15.49M | -$7.6M | -$9.14M | -$10.22M | -$3.71M | -$116K |
| Depreciation & Amortization | $456K | $972K | $941K | $898K | $781K | $775K | $781K | $218K | $101K | $53K | $44K | $42K | $1K | $116K |
| Deferred Income Tax | $0 | -$84K | $0 | $0 | $0 | $8K | $6K | -$507K | -$357K | $0 | $0 | -$1.97M | -$326K | $0 |
| Stock-Based Compensation | $1.02M | $3.19M | $4.95M | $5.23M | $4.29M | $4.56M | $2.99M | $3.83M | $3.6M | $1.52M | $1.59M | $1.97M | $326K | $0 |
| Changes in Working Capital: | ||||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $46K | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $220K | -$419K | -$103K | -$321K | $588K | -$329K | $384K | -$287K | $107K | -$22K | -$74K | -$126K | $336K | $0 |
| Other Working Capital | -$1.73M | $288K | $1.77M | -$4.47M | $947K | -$179K | -$876K | $447K | $421K | -$72K | -$250K | $370K | $62K | $0 |
| Total Working Capital Change | -$1.51M | -$131K | $1.67M | -$4.79M | $1.53M | -$509K | -$492K | $160K | $529K | -$94K | -$324K | $244K | $398K | $0 |
| Other Non-Cash Items | $3.37M | $4.41M | $108K | $504K | $1.45M | $240K | $140 | $57K | $157K | $2K | $9K | $1.97M | $326K | -$57K |
| Net Cash from Operating | -$7.01M | -$15.88M | -$15.28M | -$19.16M | -$15.22M | -$17.37M | -$14.09M | -$10.32M | -$11.46M | -$6.12M | -$7.81M | -$7.96M | -$2.99M | -$57K |
| Investing Activities | ||||||||||||||
| Capital Expenditures | $0 | $0 | -$218K | -$892K | -$260K | -$6K | -$406K | -$536K | -$942K | $0 | -$76K | -$289K | -$94K | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $8.48M | $0 | $0 | $0 | $0 | $71K | $0 | $0 | $0 |
| Purchases of Investments | $0 | -$8.44M | $0 | -$9.48M | -$23.2M | -$72.11M | -$5.61M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $17.64M | $13.46M | $15.25M | $40.23M | $31.45M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $335K | $0 | $0 | $0 | $0 | -$8.48M | -$5.61M | -$535.92M | -$942.18M | $0 | -$5.42M | -$399.61M | $0 | $0 |
| Net Cash from Investing | $335K | $9.21M | $13.24M | $4.88M | $16.77M | -$40.67M | -$6.01M | -$536K | -$942K | $0 | -$5K | -$289K | -$94K | $0 |
| Financing Activities | ||||||||||||||
| Debt Repaid | $9K | $5K | $7K | $20K | $30K | $55K | $82K | $59K | $17K | $16K | $48K | - | $24K | - |
| Common Stock Issuance | $129K | $9.18M | $0 | $99K | $5.58M | $46.7M | $30.1M | $9.24M | $1.12M | $7.16M | $10M | $0 | $15.38M | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$2K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | -$682.8M | -$2.23B | -$587.14M | -$608.34M | -$4.39B | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$29K | $0 | $0 | $0 | $1.42M | $684.2M | $2.26B | $603.07M | $622.84M | $4.39B | $8.5M | $0 | -$2.38M | $480K |
| Net Cash from Financing | $3.39M | $9.17M | -$7K | $79K | $6.96M | $48.05M | $29.85M | $15.87M | $15.6M | $7M | $8.46M | $0 | $13.5M | $480K |
| Forex Effect | $0 | $0 | $0 | $194 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$3.29M | $2.5M | -$2.04M | -$14.2M | $8.51M | -$9.99M | $9.75M | $5.01M | $3.2M | $878K | $636K | -$8.25M | $10.42M | $422K |
| Supplementary Data | ||||||||||||||
| Operating Cash Flow | -$7.01M | -$15.88M | -$15.28M | -$19.16M | -$15.22M | -$17.37M | -$14.09M | -$10.32M | -$11.46M | -$6.12M | -$7.81M | -$7.96M | -$2.99M | -$57K |
| Capital Expenditure | $0 | $0 | -$218K | -$892K | -$260K | -$6K | -$406K | -$536K | -$942K | $0 | -$76K | -$289K | -$94K | $0 |
| Free Cash Flow | -$7.01M | -$15.88M | -$15.5M | -$20.05M | -$15.48M | -$17.37M | -$14.5M | -$10.86M | -$12.4M | -$6.12M | -$7.89M | -$8.25M | -$3.08M | -$57K |
| Cash at Beginning | $7.53M | $5.04M | $7.08M | $21.08M | $12.77M | $22.76M | $13.01M | $8M | $4.11M | $3.23M | $2.59M | $10.84M | $424K | $2K |
| Cash at End | $4.25M | $7.53M | $5.04M | $6.88M | $21.28M | $12.77M | $22.76M | $13.01M | $7.31M | $4.11M | $3.23M | $2.59M | $10.84M | $424K |